Clearmind Medicine
CMND
9 hedge funds and large institutions have $5.51M invested in Clearmind Medicine in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
29% more funds holding
Funds holding: 7 → 9 (+2)
1% more capital invested
Capital invested by funds: $5.45M → $5.51M (+$60K)
0.01% more ownership
Funds ownership: 0.03% → 0.03% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$11.2K |
| 2 |
JP Morgan Chase
New York
|
+$3.46K |
| 3 |
GAM
Gotham Asset Management
New York
|
+$769 |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$384 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$14.4K |
| 2 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$14.2K |
CMND Hedge Fund Activity: Q2 2025 in Review
9 of the 7,486 institutional investors tracked by Wall St. Rank reported a position in Clearmind Medicine (CMND) for Q2 2025, worth a combined $5.51M — up 1.1% from $5.45M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CMND positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was XTX Topco, opening a new position worth an estimated $11.2K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $14.4K sold.
- 9 institutional investors held Clearmind Medicine (CMND) as of Q2 2025, up from 7 in Q1 2025.
- Funds reported $5.51M of Clearmind Medicine stock for Q2 2025, up 1.1% quarter-over-quarter.
- 3 funds opened new Clearmind Medicine positions in Q2 2025 and 1 closed out, a net change of +2 holders.
- The largest Clearmind Medicine buyer in Q2 2025 was XTX Topco, an estimated $11.2K added.
- The largest Clearmind Medicine seller in Q2 2025 was Two Sigma Securities, an estimated $14.4K sold.
Based on aggregated 13F filings for Q2 2025.